Lipoprotein and carbohydrate disorders in nephrotic syndrome and uremia.
D000273:Adipose Tissue / Q000378:metabolism; D001786:Blood Glucose / Q000032:analysis; D050260:Carbohydrate Metabolism; D002784:Cholesterol / Q000652:urine; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D005934:Glucagon / Q000494:pharmacology; D005951:Glucose Tolerance Test; D006801:Humans; D007275:Injections, Intravenous; D007328:Insulin / Q000097:blood; D007329:Insulin Antagonists; D007333:Insulin Resistance; D007676:Kidney Failure, Chronic / Q000378:metabolism*; D050356:Lipid Metabolism; D008074:Lipoproteins / Q000096:biosynthesis / Q000097:blood; D008099:Liver / Q000378:metabolism; D008297:Male; D009132:Muscles / Q000378:metabolism; D009404:Nephrotic Syndrome / Q000378:metabolism*; D014176:Protein Biosynthesis; D014044:Tolbutamide / Q000494:pharmacology; D014511:Uremia / Q000378:metabolism*
D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D007329:Insulin Antagonists; D008074:Lipoproteins; D005934:Glucagon; D002784:Cholesterol; D014044:Tolbutamide